Lumida
/ENTA
⌘K
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc

ENTA
$12.96USD+2.05%+0.26 today

MARKET CAP

377.5M

P/E (TTM)

FWD P/E

DAY RANGE

$13 – $13

52W RANGE

$7
$17

AI Summary

Stalk
Buy NowHigh

ENTA is in a Stage 2 advancement within a longer-term downtrend. Price has executed a Lockout Rally, reclaiming short- and medium-term EMAs on expanding volume and signaling urgent forced buying. Despite overbought RSI and elevated options interest, the Lockout Rally override supports continued execution readiness. Medium-term bullish permission remains intact, and a Buy Now posture is advised for continuation participation above the mid-June breakout zone.

  • Institutional investors hold 94.99% of shares, underlining strong support
  • Stock price up 64.5% over 12 months despite market headwinds
  • Q3 2026 net loss was $19.5M, versus $18.3M prior year
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income